Hochschulschrift
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
iii, 95 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 20223
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (when)
-
2023
- Creator
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:07 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Time of origin
- 2023
Other Objects (12)
New anticancer drugs
Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
Molecular aspects of anti-cancer drug action
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
Activation of apoptosis pathways by different classes of anticancer drugs
Activation of apoptosis pathways by different classes of anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Targeted drug delivery
Metal-peptide bioconjugates for targeted anti-cancer therapy
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
New anticancer drugs
Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
Molecular aspects of anti-cancer drug action
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
Activation of apoptosis pathways by different classes of anticancer drugs
Activation of apoptosis pathways by different classes of anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Targeted drug delivery
Metal-peptide bioconjugates for targeted anti-cancer therapy
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
New anticancer drugs
Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
Molecular aspects of anti-cancer drug action
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
Activation of apoptosis pathways by different classes of anticancer drugs
Activation of apoptosis pathways by different classes of anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Targeted drug delivery
Metal-peptide bioconjugates for targeted anti-cancer therapy
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors